22 May 2026Open access
Orally active bi-herbal combo of Annickia affinis and Nauclea pobeguinii displays promising potency against chloroquine resistant Plasmodium falciparumPublisher sitePhytomedicine Plus, Alkaloids: synthesis and pharmacology
UniversitiesIfeoma Ezenyi
Active, last published 2026
In malaria research and control
Ifeoma
Ezenyi
Scholar“Research focused on Malaria Research and Control and adjacent fields.”
National Institute for Pharmaceutical Research and Development
Claim Your Profile9
H-index
247
Citations
Ifeoma has not officially claimed their profile. If you are Ifeoma, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
feoma Ezenyi is a researcher working on Malaria Research and Control. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Ifeoma's work has been cited 247 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Malaria Research and Control×11Ethnobotanical and Medicinal Plants Studies×8Traditional and Medicinal Uses of Annonaceae×4Diverse Scientific Research Studies×4SARS-CoV-2 and COVID-19 Research×3
04 · Where I am
Affiliations
Affiliation on published researchNational Institute for Pharmaceutical Research and DevelopmentDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
4 works16 Dec 2025Open access
A triple-blinded randomized control trial to evaluate the safety and immunogenicity of fractional doses of COVID-19 vaccines (ChAd0x1, AD26.COV2. S, and BNT162B2) among Nigeria adults: the SIFCoVAN trialPublisher siteTrials
4 Sept 2025Open access
Issues associated with malaria self-medication in sub-Saharan Africa: A systematic literature review and meta-analysisPublisher sitePubMed, Malaria Research and Control
22 Nov 2024Open access1cites
Safety and Immunogenicity of Fractional Doses of COVID-19 Vaccines among Nigerian Adults- A Randomised Non-Inferiority trialPublisher siteExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ifeoma?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you